Effects of chronic wound fluid on the bioactivity of platelet‐derived growth factor in serum‐free medium and its direct effect on fibroblast growth
- 1 March 1999
- journal article
- research article
- Published by Wiley in Wound Repair and Regeneration
- Vol. 7 (2) , 97-105
- https://doi.org/10.1046/j.1524-475x.1999.00097.x
Abstract
The fate of biologically active proteins applied to chronic wounds is almost totally unknown. Growth factors may be degraded by proteases, which are produced by both inflammatory and skin cells and by resident bacteria. However, there has been little work on the effect of chronic wound fluid on the activity of growth factors. A bioassay method has been chosen to examine the effect of incubation of platelet-derived growth factor with chronic wound fluid from leg ulcers on the in vitro growth of human dermal fibroblasts. Human dermal fibroblasts were cultured in serum-free medium, and a dose–response curve for proliferation in response to platelet-derived growth factor was obtained. Wound fluid was collected under occlusive dressings from five patients with chronic leg ulcers. Platelet-derived growth factor was incubated with chronic wound fluid at 37 °C for 4 hours, and the reactions arrested by snap freezing. The resultant solutions were tested for their ability to promote fibroblast proliferation. A colorimetric assay was used to monitor changes in the platelet-derived growth factor mitogenicity. The results showed that, in our standard culture conditions, chronic wound fluid always stimulated fibroblast proliferation, and, in most cases, incubation of platelet-derived growth factor with chronic wound fluid increased the stimulation compared with that produced by platelet-derived growth factor or chronic wound fluid alone.Keywords
This publication has 30 references indexed in Scilit:
- Wound Fluids from Human Pressure Ulcers Contain Elevated Matrix Metalloproteinase Levels and Activity Compared to Surgical Wound FluidsJournal of Investigative Dermatology, 1996
- Effects of cytokines in burn blister fluids on fibroblast proliferation and their inhibition with the use of neutralizing antibodiesWound Repair and Regeneration, 1996
- Matrix Metalloproteinases, Gelatinase and Collagenase, in Chronic Leg UlcersJournal of Investigative Dermatology, 1996
- Fibronectin Degradation in Chronic Wounds Depends on the Relative Levels of Elastase, α1-Proteinase Inhibitor, and α2-MacroglobulinJournal of Investigative Dermatology, 1996
- Combination of platelet‐derived growth factor‐BB and insulin‐like growth factor‐I is more effective than platelet‐derived growth factor‐BB alone in stimulating complete healing of full‐thickness wounds in “older” diabetic miceWound Repair and Regeneration, 1995
- Degradation of Fibronectin and Vitronectin and Vitronectin in Chronic Wound Fluid: Analysis by Cell Blotting, Immunoblotting, and Cell Adhesion AssaysJournal of Investigative Dermatology, 1992
- Growth‐promoting activity of tissue inhibitor of metalloproteinases‐1 (TIMP‐1) for a wide range of cells A possible new growth factor in serumFEBS Letters, 1992
- Enhancement of Wound Healing by Topical Treatment with Epidermal Growth FactorNew England Journal of Medicine, 1989
- Growth Dynamics of Cultured Myofibroblasts from Human Breast Cancer and Nonmalignant Contracting TissuesPlastic and Reconstructive Surgery, 1984